Literature DB >> 26626816

Dysregulation of Neuregulin-1/ErbB signaling in the prefrontal cortex and hippocampus of rats exposed to chronic unpredictable mild stress.

Ruili Dang1, Hualin Cai2, Ling Zhang3, Donglou Liang3, Chuanfeng Lv3, Yujin Guo4, Ranyao Yang3, Yungui Zhu2, Pei Jiang5.   

Abstract

Exposure to chronic stress increases the likelihood of developing depression, but the underlying mechanisms remain equivocal. While recent evidence has indicated that Neuregulin-1 (NRG1) and its ErbB receptors play an essential role in neural development and function, and NRG1 has emerged as a novel modulator involved in the response of brain to stress, there is limited evidence concerning the effects of chronic stress exposure on NRG1/ErbB signaling. To fill this critical gap, we examined the protein expression of NRG1 and ErbB receptors in the brain of rats following chronic unpredictable mild stress (CUMS) exposure. After 6weeks of CUMS procedures, the rats were induced to a depression-like state. The stressed rats displayed elevated expression of NRG1 and phosphorylated ErbB4 (pErbB4) in the prefrontal cortex, whereas ErbB2 and pErbB2 were inhibited. In the hippocampus, CUMS also attenuated activation of the both ErbB receptors and suppressed the downstream Akt and ERK phosphorylation. Meanwhile, administration of sertraline enhanced NRG1/ErbB signaling and partly normalized the stress-induced behavioral changes and the disturbances of NRG1/ErbB system in CUMS rats. Combined, our data firstly showed the aberrant changes of NRG1/ErbB system in the brain of the animal model of depression, providing new evidence for the involvement of NRG1/ErbB pathway in the development and treatment of depression.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic unpredictable mild stress; Depression; Neuregulin-1/ErbB signaling; Sertraline

Mesh:

Substances:

Year:  2015        PMID: 26626816     DOI: 10.1016/j.physbeh.2015.11.023

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  15 in total

1.  The laterodorsal tegmentum-ventral tegmental area circuit controls depression-like behaviors by activating ErbB4 in DA neurons.

Authors:  Hongsheng Wang; Wanpeng Cui; Wenbing Chen; Fang Liu; Zhaoqi Dong; Guanglin Xing; Bin Luo; Nannan Gao; Wen-Jun Zou; Kai Zhao; Hongsheng Zhang; Xiao Ren; Zheng Yu; Heath L Robinson; Zhipeng Liu; Wen-Cheng Xiong; Lin Mei
Journal:  Mol Psychiatry       Date:  2021-05-14       Impact factor: 15.992

2.  Neuregulin 1 Deficiency Modulates Adolescent Stress-Induced Dendritic Spine Loss in a Brain Region-Specific Manner and Increases Complement 4 Expression in the Hippocampus.

Authors:  David J Clarke; Tariq W Chohan; Mustafa S Kassem; Kristie L Smith; Rose Chesworth; Tim Karl; Michael P Kuligowski; Sandra Y Fok; Maxwell R Bennett; Jonathon C Arnold
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

3.  Quantification of Tyrosine Hydroxylase and ErbB4 in the Locus Coeruleus of Mood Disorder Patients Using a Multispectral Method to Prevent Interference with Immunocytochemical Signals by Neuromelanin.

Authors:  Lei Guo; Jochem Stormmesand; Zheng Fang; Qingbin Zhu; Rawien Balesar; Joop van Heerikhuize; Arja Sluiter; Dick Swaab; Ai-Min Bao
Journal:  Neurosci Bull       Date:  2019-01-31       Impact factor: 5.203

4.  Prenatal dexamethasone exposure induces anxiety- and depressive-like behavior of male offspring rats through intrauterine programming of the activation of NRG1-ErbB4 signaling in hippocampal PV interneurons.

Authors:  Shuai Zhang; Shuwei Hu; Wanting Dong; Songqiang Huang; Zhexiao Jiao; Zewen Hu; Shiyun Dai; Yiwen Yi; Xiaohan Gong; Ke Li; Hui Wang; Dan Xu
Journal:  Cell Biol Toxicol       Date:  2021-06-29       Impact factor: 6.691

5.  Dysregulation of Neuregulin-1/ErbB signaling in the hippocampus of rats after administration of doxorubicin.

Authors:  Dehua Liao; Yujin Guo; Daxiong Xiang; Ruili Dang; Pengfei Xu; Hualin Cai; Lizhi Cao; Pei Jiang
Journal:  Drug Des Devel Ther       Date:  2018-01-30       Impact factor: 4.162

6.  The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.

Authors:  Xiaocong Pang; Ying Zhao; Jinhua Wang; Qimeng Zhou; Lvjie Xu; Ai-Lin Liu; Guan-Hua Du
Journal:  Biomed Res Int       Date:  2017-11-21       Impact factor: 3.411

Review 7.  Epigenetic Programming of Synthesis, Release, and/or Receptor Expression of Common Mediators Participating in the Risk/Resilience for Comorbid Stress-Related Disorders and Coronary Artery Disease.

Authors:  Carlos Manuel Zapata-Martín Del Campo; Martín Martínez-Rosas; Verónica Guarner-Lans
Journal:  Int J Mol Sci       Date:  2018-04-18       Impact factor: 5.923

8.  Therapeutic Effect of Berberine on Insomnia Rats by ErbB Signaling Pathway.

Authors:  Qingquan Wang; Xiaojuan Ren; Xingping Zhang; Guanying Wang; Hongxia Xu; Ning Deng; Tao Liu; Zhipeng Peng
Journal:  Med Sci Monit       Date:  2020-07-05

9.  Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression.

Authors:  Lucia Carboni; Luca Marchetti; Mario Lauria; Peter Gass; Barbara Vollmayr; Amanda Redfern; Lesley Jones; Maria Razzoli; Karim Malki; Veronica Begni; Marco A Riva; Enrico Domenici; Laura Caberlotto; Aleksander A Mathé
Journal:  Neuropsychopharmacology       Date:  2018-06-12       Impact factor: 7.853

10.  Sex-Specific Role for the Long Non-coding RNA LINC00473 in Depression.

Authors:  Orna Issler; Yentl Y van der Zee; Aarthi Ramakrishnan; Junshi Wang; Chunfeng Tan; Yong-Hwee E Loh; Immanuel Purushothaman; Deena M Walker; Zachary S Lorsch; Peter J Hamilton; Catherine J Peña; Erin Flaherty; Brigham J Hartley; Angélica Torres-Berrío; Eric M Parise; Hope Kronman; Julia E Duffy; Molly S Estill; Erin S Calipari; Benoit Labonté; Rachael L Neve; Carol A Tamminga; Kristen J Brennand; Yan Dong; Li Shen; Eric J Nestler
Journal:  Neuron       Date:  2020-04-17       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.